SPYRAL GEMINI Pilot Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 175 participants.

Also called NCT06907147

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 175 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06907147
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Germany, Greece, Ireland, Switzerland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06907147. Non-randomized; no masking; primary purpose treatment. Start 2025-05-01 (actual); primary completion 2029-12-22 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SPYRAL GEMINI Pilot Study
Acronym
SPYRAL GEMINI
Condition
Hypertension
Condition
Vascular Diseases
Condition
Cardiovascular Diseases
Condition
Chronic Kidney Diseases
Condition
Diabetes Mellitus
Intervention (Device)
Multi-Organ Denervation Gemini System
Lead sponsor
Medtronic Vascular (class: industry)

Record details

Record id
cardio:ct-nct06907147
Content hash
3f09a1627ceb56db441e47cb9adfbe186c09febad67ea410a99783b8a90e9604